Ezra T. Ernst left the role of Director at XWELL, Inc. As of November 6, 2026, XWELL, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on August 5, 2026, naming 1 appointment and 1 departure (Form 8-K, August 5, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like XWELL, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
XWELL, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-05. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as XWELL, Inc. files it.
Also on the record for XWELL, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 8, 2026 | Stake report, Schedule 13D/A, by American Ventures LLC, Series XXIV XWELL | 9.975% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G/A, by Richard Abbe | 5.5% of the class | 5%+ stakes | Source |
| August 12, 2026 | Stake report, Schedule 13G/A, by Iroquois Capital Management, LLC | — | 5%+ stakes | Source |
| August 4, 2026 | Stake report, Schedule 13D, by Bruce Bernstein | 6.9% of the class | 5%+ stakes | Source |
| June 11, 2026 | Stake report, Schedule 13G, by Richard Abbe | 5.14% of the class | 5%+ stakes | Source |
| March 18, 2026 | Stake report, Schedule 13D, by American Ventures LLC, Series XXIV XWELL | 4.99% of the class | 5%+ stakes | Source |
| March 11, 2026 | Stake report, Schedule 13G, by McCabe James Joseph III | 5.5% of the class | 5%+ stakes | Source |
| March 3, 2026 | Form D, private offering | $31M sold | Form D page | Source |
| January 28, 2025 | Form D, private offering | $4M sold | Form D page | Source |
| April 20, 2023 | Court case: Bunting v. Xwell, Inc., District Court, E.D. New York | — | Court records | Source |
Selling to them or working with them? See who runs XWELL, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on XWELL, Inc. and the records around it.
The people at XWELL, Inc.
- Bruce Bernstein is also named on 4 other Form D filings: TNF Pharmaceuticals, Inc. (Sep 2025), Synaptogenix, Inc. (Jun 2025)
- Robert Weinstein is also named on 2 other Form D filings: Synaptogenix, Inc. (Jun 2025)
XWELL, Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
- Company profile and every filing Mar 2026
- Form D filing Mar 2026
- Who owns it
Companies that share a holder
- Iroquois Capital Management, LLC also filed stake reports on 13 other companies: 22nd Century Group (Aug 2026), Clearmind Medicine Inc. (Aug 2026), SCWorx Corp. (Aug 2026)
Watch XWELL, Inc.
Get an email when XWELL, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on XWELL, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on XWELL, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on XWELL, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-05 | Out | Director | 8-K, 2026-08-05 | ||
| 2026-08-05 | In | Director | 8-K, 2026-08-05 |
Who leads XWELL, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Ezra T. Ernst, departure reported (filed 2026-08-05). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on XWELL, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportWatch XWELL, Inc. (free up to 3)
Find people with the same kind of experience as the Director at XWELL, Inc., with the record behind each one.
Find candidates like Director at XWELL, Inc.Every change, in the filing's words
Departing: Ezra T. Ernst, Director
On August 3, 2026, Ezra T. Ernst, the President, Chief Executive Officer and director of XWELL, Inc. (the "Company"), notified the Company of his resignation as a director of the Company's Board of Directors (the "Board") and all committees of the Board thereto, effective as of the same date.
Appointed: Gerard Reid, Director
On August 3, 2026, the Board appointed Gerard Reid as a director of the Board, effective as of the same date, to fill the vacancy resulting from Mr. Ernst's resignation.
- Mr. Ernst's resignation from the Board was not in connection with any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- Mr. Ernst will continue to serve as President and Chief Executive Officer of the Company.
- Mr. Reid will be entitled to participate in the Company's compensation policy for non-employee directors, which consists of an annual fee, payable in cash, of $35,000 per year for service on the Board.
Tools for this story
Each opens in a new tab, filled in for XWELL, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.